Novo Nordisk A/S (NOVO-B.CO)

Exchange: Copenhagen Exchange
Currency: DKK

Price: 741.60 (Close)



52 Week range 200d Moving Avg. Beta
413.01 – 773.70 651.68 0.31
Dividend Dividend Yield Ex-Dividend date
10.40 1.40% 2022-03-25
P/E Ratio Latest EPS DGR 3 years
35.92 20.74 6.00%
Very low Volatility
Dividend Growth


Novo Nordisk A/S, a healthcare company, engages in the development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Obesity, and Biopharmaceuticals. The Diabetes Care and Obesity segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral anti-diabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company has a strategic alliance with Evotec AG to discover and develop small molecule therapies to treat patients suffering from diabetes, obesity, and co-morbidities, as well as has a research collaboration with Kallyope Inc. It also has collaboration agreements with Lund University to develop stem cell-derived treatment for Parkinson’s diseases; Staten Biotechnology B.V. to develop novel therapeutics for the treatment of dyslipidaemia; Medtronic plc to develop integrated digital solutions for people with diabetes; and bluebird bio, Inc. to develop in vivo genome editing treatments for genetic diseases. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.


Sector: Industry:
Healthcare Biotechnology

Environment, Social and Governance (ESG) Ratings

Total ESG Score

26 – 31 percentile


3 – 5 percentile


15 – 5 percentile


13 – 5 percentile

Controversy level



see MSCI ESG rating explained

Dividend Safety Metrics

Latest EPS 20.74
Annual Payout 10.40
Payout Ratio 50.14%
Dividend growth 22 Years
Dividend Score 71
Dividend Coverage Ratio 1.99
Altman-Z score 0.00


Novo Nordisk A/S (NOVO-B.CO) Valuation

Novo Nordisk A/S current dividend yield of 1.40% is -32% below its 5-year average. The 5-year average dividend yield is 2.06% (see red-line in chart). This indicates the stock looks overvalued today.

Novo Nordisk A/S (NOVO-B.CO) Performance

The chart below displays the total price return(%) of Novo Nordisk A/S for different periods:


Novo Nordisk A/S (NOVO-B.CO) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of Novo Nordisk A/S for different periods:


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
1.40 10.40 50.14% 22 Years


Dividend Growth Summary

3 Year Growth Rate (CAGR) 6.00%
5 Year Growth Rate (CAGR) -0.11%
10 Year Growth Rate (CAGR) 16.68%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2021 9.350 8.7%
2020 8.600 5.5%
2019 8.150 3.8%
2018 7.850 3.3%
2017 7.600 -19.1%
2016 9.400 88.0%
2015 5.000 11.1%
2014 4.500 25.0%
2013 3.600 28.6%
2012 2.800 40.0%
2011 2.000 33.3%
2010 1.500 25.0%
2009 1.200 33.3%
2008 0.900 28.6%

Novo Nordisk A/S (NOVO-B.CO) Dividend Payment History